Details for Patent: 7,601,758
✉ Email this page to a colleague
Which drugs does patent 7,601,758 protect, and when does it expire?
Patent 7,601,758 protects COLCRYS and is included in one NDA.
Summary for Patent: 7,601,758
| Title: | Methods for concomitant administration of colchicine and macrolide antibiotics in the treatment of gout flares |
| Abstract: | Methods for treating gout flares comprising concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin or erythromycin, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for co-administration of colchicine together with macrolide antibiotics are also provided. |
| Inventor(s): | Davis; Matthew W. (Erwinna, PA) |
| Assignee: | Mutual Pharmaceutical Company, Inc. (Philadelphia, PA) |
| Application Number: | 12/368,700 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,601,758 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 7,601,758
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | COLCRYS | colchicine | TABLET;ORAL | 022352-001 | Jul 29, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING GOUT FLARES | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
